| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |